<DOC>
	<DOCNO>NCT02104765</DOCNO>
	<brief_summary>The main purpose study evaluate safety study drug know LY2951742 healthy Japanese Caucasians . The study also investigate body process drug drug affect body . The study expect last 5 7 month , depend arm .</brief_summary>
	<brief_title>A Study LY2951742 Healthy Japanese Caucasian Participants</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Participants either Caucasian first generation Japanese . Participants ' body mass index ( BMI ) 18.0 35.0 kilogram per meter square ( kg/ m^2 ) . Participants heavy caffeine drinker define regular intake 5 cup coffee ( equivalent xanthine contain beverage ) per day , and/or unable unwilling abide caffeine restriction specify protocol . Participants smoke within previous 6 month . Participants receive treatment biologic agent ( monoclonal antibody ) within 3 month 5 halflives ( whichever longer ) prior dose receive vaccination within 1 month . Participants know allergy LY2951742 , related compound component formulation , history significant atopy . Participants allergies either humanized monoclonal antibody , diphenhydramine , epinephrine , methylprednisolone .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>